These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35466125)

  • 1. Challenges in the screening and treatment of latent multidrug-resistant tuberculosis infection.
    Deng G; Zhang P; Lu H
    Drug Discov Ther; 2022 May; 16(2):52-54. PubMed ID: 35466125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].
    Catho G; Sénéchal A; Ronnaux-Baron AS; Valour F; Perpoint T; Bouaziz A; Dumitriescu O; Reix P; Pedone C; Ader F;
    Rev Pneumol Clin; 2015 Dec; 71(6):335-41. PubMed ID: 26195117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Bamrah S; Brostrom R; Dorina F; Setik L; Song R; Kawamura LM; Heetderks A; Mase S
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):912-8. PubMed ID: 25199004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Marks SM; Mase SR; Morris SB
    Clin Infect Dis; 2017 Jun; 64(12):1670-1677. PubMed ID: 28329197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.
    Fox GJ; Nguyen CB; Nguyen TA; Tran PT; Marais BJ; Graham SM; Nguyen BH; Velen K; Dowdy DW; Mason P; Britton WJ; Behr MA; Benedetti A; Menzies D; Nguyen VN; Marks GB
    BMJ Open; 2020 Jan; 10(1):e033945. PubMed ID: 31900274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Fox GJ; Anh NT; Nhung NV; Loi NT; Hoa NB; Ngoc Anh LT; Cuong NK; Buu TN; Marks GB; Menzies D
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):297-302. PubMed ID: 28225339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
    Migliori GB; Tiberi S; Zumla A; Petersen E; Chakaya JM; Wejse C; Muñoz Torrico M; Duarte R; Alffenaar JW; Schaaf HS; Marais BJ; Cirillo DM; Alagna R; Rendon A; Pontali E; Piubello A; Figueroa J; Ferlazzo G; García-Basteiro A; Centis R; Visca D; D'Ambrosio L; Sotgiu G;
    Int J Infect Dis; 2020 Mar; 92S():S15-S25. PubMed ID: 32032752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis Burden among Household Pediatric Contacts of Adult Tuberculosis Patients.
    Dayal R; Agarwal D; Bhatia R; Bipin C; Yadav NK; Kumar S; Narayan S; Goyal A
    Indian J Pediatr; 2018 Oct; 85(10):867-871. PubMed ID: 29557089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan.
    Huang YW; Shen GH; Lee JJ; Yang WT
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1430-5. PubMed ID: 20937183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in research of prophylactic therapy in contacts of rifampicin-resistant tuberculosis patients].
    Wang Z; Wang WJ; Ding XY; Lu P; Zhu LM; Liu Q; Lu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Mar; 44(3):470-476. PubMed ID: 36942344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
    Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ
    Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.
    Huerga H; Sanchez-Padilla E; Melikyan N; Atshemyan H; Hayrapetyan A; Ulumyan A; Bastard M; Khachatryan N; Hewison C; Varaine F; Bonnet M
    Arch Dis Child; 2019 Jul; 104(7):622-628. PubMed ID: 30523172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health response to a multidrug-resistant tuberculosis outbreak among Guatemalans in Tennessee, 2007.
    Miramontes R; Lambert L; Haddad MB; Boaz V; Hawkins S; Zylstra M; Allen R; Rivers S; Ali B; Chewning SS; Holt E; Warkentin J
    South Med J; 2010 Sep; 103(9):882-6. PubMed ID: 20689483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
    Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
    Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2014; 58(4):2316-21. PubMed ID: 24492372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.
    Pradipta IS; Forsman LD; Bruchfeld J; Hak E; Alffenaar JW
    J Infect; 2018 Dec; 77(6):469-478. PubMed ID: 30339803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculous infection prevalence among paediatric contacts of drug-resistant and drug-susceptible cases.
    Laniado-Laborín R; Cazares-Adame R; Volker-Soberanes ML; del Portillo-Mustieles C; Villa-Rosas C; Oceguera-Palao L; Magallanes-Mijares J
    Int J Tuberc Lung Dis; 2014 May; 18(5):515-9. PubMed ID: 24903785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer Drugs for Tuberculosis Prevention and Treatment in Children.
    Marais BJ
    Indian J Pediatr; 2019 Aug; 86(8):725-731. PubMed ID: 30707347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant tuberculosis and migration to Europe.
    Hargreaves S; Lönnroth K; Nellums LB; Olaru ID; Nathavitharana RR; Norredam M; Friedland JS
    Clin Microbiol Infect; 2017 Mar; 23(3):141-146. PubMed ID: 27665703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.